Anesthetic drugs & techniques

Intravenous lidocaine with propofol‐based sedation for colonoscopy: a systematic review and meta‐analysis with trial sequential analysis

AnaesthesiaPublished Systematic review and meta-analysis of randomised trials

Pooled result · Propofol consumption during the procedureResult — go to the resultMean difference −42.93 mg 95% CI −62.89 to −22.97

Authors' conclusion

In patients undergoing colonoscopy, the addition of intravenous lidocaine to propofol-based sedation reduced propofol consumption, shortened awakening time, mitigated post-procedural pain and enhanced patient satisfaction compared with placebo.

Study context

Population
Patients undergoing colonoscopy with propofol-based sedation
Participants
520 patients · 8 RCTs
Comparison
IV lidocaine vs placebo as adjuvant to propofol-based sedation
Outcome
Total propofol dose
Methodological detailstrial sequential analysis, random-effects model
  • Trial sequential analysis
  • Random-effects model

Pooled result

Propofol consumption during the procedure

Mean difference

−42.93 mg

95% CI −62.89 to −22.97

Lidocaine vs Placebo
mean difference −42.93 mg (95% CI −62.89 to −22.97)

As reported in the abstract

Further pooled results

OutcomeMean difference (minutes) (95% CI)
Awakening time−3.38 (−5.92 to −0.84)
OutcomeMean difference (95% CI)
Post-procedural pain scores−1.38 (−2.72 to −0.04)
Patient satisfaction scores0.50 (0.30–0.70)

Procedure duration and endoscopist satisfaction scores

No significant differences between the groups

Safety

No significant differences between the groups in risk of hypoxia or hypotension

Original publication

Intravenous lidocaine with propofol‐based sedation for colonoscopy: a systematic review and meta‐analysis with trial sequential analysis. Anaesthesia. Published 18 March 2025. doi:10.1111/anae.16563

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.